Annabel Samimy
Stock Analyst at Stifel
(1.59)
# 1638
Out of 5,218 analysts
91
Total ratings
42.42%
Success rate
21.90%
Average return
Main Sectors:
Top Industries:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
Inventiva | Maintains: Buy | 20 17 | 2.42 | 602.48% | 4 | Nov 22, 2024 | |
MBX Biosciences | Initiates Coverage On: Buy | 40 | 19.15 | 108.88% | 1 | Oct 8, 2024 | |
Revance Therapeutics | Maintains: Buy | 24 20 | 3.08 | 549.35% | 3 | Aug 9, 2024 | |
Kamada | Initiates Coverage On: Buy | 18 | 5.8 | 210.34% | 1 | Jul 3, 2024 | |
Calliditas Therapeut... | Downgrades: Hold | 55 40 | n/a | n/a | 2 | May 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 24 | 7.87 | 204.96% | 1 | May 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 40 | 8.27 | 383.68% | 2 | Apr 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 80 | 46.98 | 70.29% | 6 | Mar 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 225 230 | 123 | 86.99% | 4 | Mar 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Strong Buy | 23 25 | 11.51 | 117.2% | 1 | Mar 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 35 | 17.03 | 105.52% | 1 | Oct 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 60 65 | 33.24 | 95.55% | 3 | Aug 29, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 110 173 | n/a | n/a | 2 | Jul 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 28 | 0.26 | 10669.23% | 3 | Jun 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 28 11 | 0.33 | 3233.33% | 4 | Jun 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 155 200 | n/a | n/a | 2 | Apr 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 45 | 11.83 | 280.39% | 1 | Mar 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 138 117 | n/a | n/a | 7 | Dec 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 8 | 1.01 | 692.08% | 1 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 375 63 | n/a | n/a | 2 | Oct 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 28 35 | n/a | n/a | 2 | Sep 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 27 16 | n/a | n/a | 2 | Aug 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 50 15 | n/a | n/a | 3 | Jun 30, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 24 | 1.65 | 1354.55% | 1 | Aug 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Hold | 20 | 17.49 | 14.35% | 1 | Apr 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 700 750 | 1.22 | 61375.41% | 2 | Apr 16, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Hold | 25 24 | 36.16 | -33.63% | 6 | Apr 16, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 71 70 | n/a | n/a | 3 | Nov 8, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Hold | 15 21 | 0.74 | 2737.84% | 4 | Sep 18, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Hold | 20 8 | n/a | n/a | 6 | Sep 9, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Hold | 10 17 | n/a | n/a | 4 | Aug 9, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | n/a | n/a | n/a | 1 | Jan 3, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | n/a | n/a | n/a | 1 | Mar 23, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | n/a | n/a | n/a | 1 | Mar 17, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Terminates Coverage On: | n/a | n/a | n/a | 1 | Mar 23, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | n/a | n/a | n/a | 1 | Mar 21, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | n/a | n/a | n/a | 1 | Mar 17, 2016 |